Cart
sales@molnova.com
Dorsomorphin dihydrochloride
CAS No. 1219168-18-9
Dorsomorphin dihydrochloride ( BML-275 dihydrochloride;Compound C dihydrochloride )
Catalog No. M10824 CAS No. 1219168-18-9
Dorsomorphin (BML-275, Compound C) is a potent, selective and reversible AMPK inhibitor with Ki of 109 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 222 | In Stock |
|
| 100MG | 402 | In Stock |
|
| 500MG | 888 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDorsomorphin dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDorsomorphin (BML-275, Compound C) is a potent, selective and reversible AMPK inhibitor with Ki of 109 nM.
-
DescriptionDorsomorphin (BML-275, Compound C) is a potent, selective and reversible AMPK inhibitor with Ki of 109 nM, shows no no significant activity on ZAPK, SYK, PKCθ, PKA and JAK3; inhibits AMPK activation induced by AICAR and Metformin, also inhibits bone morphogenetic protein (BMP) type I receptors (ALK2, ALK3 and ALK6); promotes cardiomyogenesis in mouse embryonic stem cells (ESCs) in vitro, induces autophagy in cancer cell lines via a mechanism independent of AMPK inhibition.
-
SynonymsBML-275 dihydrochloride;Compound C dihydrochloride
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1219168-18-9
-
Formula Weight472.40
-
Molecular FormulaC24H27Cl2N5O
-
Purity>98% (HPLC)
-
SolubilityH2O: ≥ 48 mg/mL; DMSO: 5.2 mg/mL (Need ultrasonic)
-
SMILESCl.Cl.C(CN1CCCCC1)OC1=CC=C(C=C1)C1=CN2N=CC(=C2N=C1)C1=CC=NC=C1
-
Chemical NamePyrazolo[1,5-a]pyrimidine, 6-[4-[2-(1-piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-, hydrochloride (1:2)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu PB, et al. Nat Chem Biol. 2008 Jan;4(1):33-41.
2. Vucicevic L, et al. Autophagy. 2011 Jan;7(1):40-50.
3. Diekmann U, et al. Stem Cells Dev. 2015 Jan 15;24(2):190-204.
4. Zhou G, et al. J Clin Invest. 2001 Oct;108(8):1167-74.
2. Vucicevic L, et al. Autophagy. 2011 Jan;7(1):40-50.
3. Diekmann U, et al. Stem Cells Dev. 2015 Jan 15;24(2):190-204.
4. Zhou G, et al. J Clin Invest. 2001 Oct;108(8):1167-74.
molnova catalog
related products
-
Cimiracemoside C
Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
-
Dorsomorphin
Dorsomorphin (BML-275, Compound C) is a potent, selective and reversible AMPK inhibitor with Ki of 109 nM.
-
1-HEXACOSANOL
Hexacosanol activates AMPK and hepatic autophagy and inhibits SREBP2, resulting in hypocholesterolemic activities and improvement of hepatic steatosis.
